Table 2.
Lead [ln (μg/dL)] |
Hemoglobin (g/dL) |
|||||
---|---|---|---|---|---|---|
Model | Genotype | n | β-Coefficient (95% CI) | p-Value | β-Coefficient (95% CI) | p-Value |
−4.22 (−7.10 to −1.36) | 0.004 | 2.30 (1.26 to 3.08) | < 0.0001 | |||
2: Stratified model | A1/A1 | 73 | −9.12 (−18.08 to −0.16) | 0.047 | −1.82 (−5.28 to 1.64) | 0.306 |
A1/A2 | 290 | −4.35 (−8.24 to −0.44) | 0.023 | 2.24 (0.57 to 3.91) | 0.001 | |
A2/A2 | 354 | −3.87 (−8.28 to 0.54) | 0.009 | 3.03 (1.60 to 4.45) | < 0.0001 | |
3: Stratified model | A1/A1 | 73 | −9.12 (−18.08 to −0.16) | 0.046 | −1.82 (−5.28 to 1.64) | 0.302 |
A1/A2 + A2/A2 | 644 | −4.00 (−7.21 to −0.69) | 0.017 | 2.72 (1.58 to 3.86) | < 0.0001 | |
4: Interaction modelb | A1/A1 | 717 | −7.27 (−17.53 to −0.20) | > 0.28c | −1.32 (−4.66 to 2.02) | 0.022c |
A1/A2 + A2/A2 | −3.94 (−7.10 to −0.79) | 2.72 (1.60 to 3.84) |
Controlling for midarm circumference, age, sex, family income, parental education, and family size and accounting for school and classroom levels.
The model assessing the interaction of lead and DRD2 Taq IA controlled for confounding by hemoglobin and vice versa for the model assessing hemoglobin and DRD2 Taq IA interaction.
p-Values for interaction term coefficients.